Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE NxStage Medical, Inc.
NxStage Patient Advocates to travel the East Coast to share the benefits of home hemodialysis
LAWRENCE, Mass., July 16, 2014 /PRNewswire/ -- NxStage® Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, announced today the launch of the NxStage Freedom Tour, a two week road trip in a recreational vehicle to promote and educate dialysis patients on the benefits of home hemodialysis with the NxStage System One™. Traveling in the NxStage Freedom Coach are NxStage field marketing specialists Charissa Rice and Harvey Wells. During the nine city tour, the duo will make stops outside of dialysis centers in Maryland, Pennsylvania, Connecticut, Massachusetts, New Jersey, New York, Virginia and North Carolina. Patients and care partners are invited inside the NxStage Freedom coach to watch Rice, who is also a NxStage user, perform her treatments with her care partner, learn about home hemodialysis and hear first-hand how the therapy has helped both Rice and Wells to reclaim their lives.
"NxStage has given me the freedom to live my life the way I want to live it," said Rice. "I want to help patients like me understand that they can have the life they want, and show them how great I feel, how happy I am, and how independently I live."
Rice performed home hemodialysis with the NxStage System One from 2009 until she received a transplant in 2011. She returned to NxStage therapy after her transplant failed in 2013, knowing home hemodialysis would help her lead the life she wanted. Wells, began in-center treatment following the failure of his first kidney transplant in 2006, then began dialyzing with the System One from the comfort of his home in 2007 until he received a second transplant in 2011. During the last three years of Wells' therapy, he teamed up with NxStage and travelled more than 60,000 miles to 150 dialysis centers helping to increase awareness among patients, care partners and dialysis professionals about the potentially life-changing benefits of home hemodialysis.
"With kidney failure, many patients feel they can no longer enjoy travel because they are tethered to the dialysis center, and arranging for treatment while away can be daunting and inconvenient," said Joe Turk, NxStage's president. "We want to show people that with NxStage, travelling away from the center is once again a possibility, along with the simpler things in life like quality time with family and an active lifestyle."
To learn more about the NxStage Freedom Tour and where to meet Harvey and Charissa visit http://bit.ly/1qoeJjO. To learn more about NxStage and the System One, visit www.nxstage.com . Join the conversation on Facebook at facebook.com/NxStage, Twitter at @NxStage and YouTube at youtube.com/user/NxStage.
Despite the health benefits that home hemodialysis may provide to those with chronic kidney disease, this form of therapy is not for everyone. The reported benefits of home hemodialysis may not be experienced by all patients. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream and blood loss due to clotting or accidental disconnection of the blood tubing set. Certain risks are unique to the home. Treatments at home are done without the presence of medical personnel and on-site technical support. Patients and their partners must be trained on what to do and how to get medical or technical help if needed.
About the NxStage System One
The NxStage System One is the first and only truly portable hemodialysis system cleared for home use by the U.S. Food & Drug Administration (FDA). Its simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients' homes and give patients the freedom to travel with their therapy. When combined with the NxStage Pureflow SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid. Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs - at home or on vacation and at a medically appropriate treatment frequency. http://www.nxstage.com/.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended March 31, 2014. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
©2012 PR Newswire. All Rights Reserved.